Shares of Vitamin Shoppe Inc. (NYSE:VSI) were down 5.4% on Thursday . The company traded as low as $29.74 and last traded at $29.99, with a volume of 191,501 shares. The stock had previously closed at $31.70.

A number of analysts have weighed in on VSI shares. Piper Jaffray Cos. reissued a “neutral” rating and set a $30.00 target price on shares of Vitamin Shoppe in a report on Friday, April 15th. Zacks Investment Research cut shares of Vitamin Shoppe from a “hold” rating to a “sell” rating in a report on Wednesday, April 20th. Wedbush started coverage on shares of Vitamin Shoppe in a report on Wednesday, April 20th. They set an “outperform” rating and a $39.00 target price on the stock. Robert W. Baird reissued a “hold” rating on shares of Vitamin Shoppe in a report on Tuesday, April 26th. Finally, Goldman Sachs Group Inc. cut shares of Vitamin Shoppe to a “hold” rating in a report on Saturday, April 30th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and two have given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $32.82.

The stock’s 50-day moving average price is $30.85 and its 200 day moving average price is $29.92. The company has a market capitalization of $703.25 million and a PE ratio of 16.82.

Vitamin Shoppe (NYSE:VSI) last posted its quarterly earnings results on Wednesday, May 4th. The company reported $0.67 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.65 by $0.02. The business had revenue of $336.80 million for the quarter, compared to analyst estimates of $339.76 million. The firm’s quarterly revenue was up .0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.63 EPS. Equities research analysts forecast that Vitamin Shoppe Inc. will post $2.32 earnings per share for the current fiscal year.

In other Vitamin Shoppe news, Director Guillermo Marmol purchased 1,000 shares of the firm’s stock in a transaction on Tuesday, May 31st. The shares were purchased at an average price of $30.23 per share, for a total transaction of $30,230.00. Following the completion of the purchase, the director now directly owns 1,470 shares of the company’s stock, valued at $44,438.10. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website.

A number of large investors have bought and sold shares of VSI. Principal Financial Group Inc. increased its stake in Vitamin Shoppe by 7.4% in the fourth quarter. Principal Financial Group Inc. now owns 199,248 shares of the company’s stock worth $6,516,000 after buying an additional 13,789 shares in the last quarter. State of Wisconsin Investment Board increased its stake in Vitamin Shoppe by 0.8% in the fourth quarter. State of Wisconsin Investment Board now owns 159,102 shares of the company’s stock worth $5,203,000 after buying an additional 1,229 shares in the last quarter. California State Teachers Retirement System increased its stake in Vitamin Shoppe by 1.6% in the fourth quarter. California State Teachers Retirement System now owns 55,107 shares of the company’s stock worth $1,802,000 after buying an additional 885 shares in the last quarter. Gabelli Funds LLC increased its stake in Vitamin Shoppe by 15.2% in the fourth quarter. Gabelli Funds LLC now owns 53,040 shares of the company’s stock worth $1,734,000 after buying an additional 7,000 shares in the last quarter. Finally, Rhumbline Advisers increased its stake in Vitamin Shoppe by 4.3% in the fourth quarter. Rhumbline Advisers now owns 45,118 shares of the company’s stock worth $1,475,000 after buying an additional 1,855 shares in the last quarter.

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, which includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats; direct, which sells its products directly to consumers through the Internet, primarily at www.vitaminshoppe.com, and manufacturing, which provides custom manufacturing and private labeling of vitamin, mineral and supplement (VMS) products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.